Page 1 of Clinical Trials for Drug Placebo to Salmeterol, 86 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD)
Last Updated: July 22, 2011
Condition(s): Chronic Obstructive Pulmonary Disease
2
Completed
Efficacy and Safety of Different Doses of Indacaterol
Last Updated: July 22, 2011
Condition(s): Asthma
3
Completed
Safety and Efficacy of Indacaterol Once Daily Versus Salmeterol Twice Daily in Chronic Obstructive Pulmonary Disease (COPD)
Last Updated: July 22, 2011
Condition(s): Chronic Obstructive Pulmonary Disease (COPD)
4
Completed
Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma
Last Updated: August 25, 2011
Condition(s): Asthma
5
Completed
Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Using Salmeterol as Active Control
Last Updated: July 22, 2011
Condition(s): Chronic Obstructive Pulmonary Disease (COPD)
6
Completed
Study of Indacaterol Dosed in the Evening in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Last Updated: July 22, 2011
Condition(s): Chronic Obstructive Pulmonary Disease (COPD)
7
Completed
Study to Determine the Onset of Action of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Last Updated: September 7, 2011
Condition(s): Chronic Obstructive Pulmonary Disease
8
Active, not recruiting
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Last Updated: May 11, 2012
Condition(s): Asthma
9
Active, not recruiting
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Last Updated: May 11, 2012
Condition(s): Asthma
10
Completed
Effect of Salmeterol on Fluid Clearance From Alveolar-Capillary Membrane in COPD Patients
Last Updated: January 5, 2011
Condition(s): Salmeterol Effect Against an Acute Alveolar Fluid Clearance Challenge Secondary to Lung Fluid Overload in COPD Patients; Chronic Obstructive Pulmonary Disease; Bronchodilator Agents; Salmeterol
11
Recruiting
Efficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease
Last Updated: May 11, 2012
Condition(s): Chronic Obstructive Pulmonary Disease
12
Completed
Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients.
Last Updated: May 18, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
13
Terminated
Tiotropium/Salmeterol Inhalation Powder (Spiriva Handihaler and Salmeterol PE Capsule) in COPD
Last Updated: July 13, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive
14
Completed
Montelukast Compared With Placebo and Salmeterol in Exercise-Induced Bronchoconstriction
Last Updated: May 27, 2010
Condition(s): Asthma, Exercise-Induced
15
Terminated
Tiotropium/Salmeterol Inhalation Powder in COPD
Last Updated: July 14, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive
16
Completed
Dose Ranging Study for Indacaterol in Japanese Asthma Patients
Last Updated: July 22, 2011
Condition(s): Asthma
17
Completed
Interactive Acute Smooth Muscle Effects of Salmeterol and Fluticasone in the Airway
Last Updated: October 29, 2010
Condition(s): Asthma
18
Completed
Efficacy and Safety of Tiotropium and Salmeterol in Moderate Persistent Asthma Patients Homozygous for B16-Arg/Arg
Last Updated: May 18, 2012
Condition(s): Asthma
19
Completed
A Crossover Study to Determine the 24 Hour Lung Function Profile of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Last Updated: July 22, 2011
Condition(s): Chronic Obstructive Pulmonary Disease
20
Not yet recruiting
Effect of an Inhaled Glucocorticoid-long-acting Beta Adrenergic Agonist on Endothelial Function in COPD
Last Updated: September 24, 2010
Condition(s): COPD

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Placebo+to+Salmeterol

Page 1 of Clinical Trials for Drug Placebo to Salmeterol, 86 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About